Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches &

Status Completed

Clinical Trial Summary

The goal of this observational study is to investigate the correlation and quantitative relationship between the analgesic effect of fentanyl transdermal patches in cancer pain patients and their nutritional status.

Clinical Trial Description

Cancer-related pain is one of the most common and unbearable symptoms among patients with malignant tumors. Opioids are commonly used to treat moderate or severe cancer pain. Among them, fentanyl is a synthetic opioid with analgesic adjuvant with a 50~100 times higher potency than morphine. Due to its small molecular weight, high lipid solubility, and low irritation to the skin, transdermal fentanyl (TDF) is formulated, which is more convenient for patients with intestinal obstruction, swallowing difficulties, and intolerance to oral opioids. According to some research, the TDF demonstrated good cancer pain control for patients switching from morphine or oral oxycodone preparations, and was well tolerated. However, a part of patients still go through increased breakthrough pain, sleep disturbances, and even accompanied by anxiety and depression when using TDF. Therefore, early identification of cancer pain patients using TDF at risk of ineffectiveness is an essential step in increasing analgesic effectiveness, and improving quality of life. Some studies discovered different clinical factors such as age, gender, serum albumin, glomerular filtration rate, kidney disease, body mass index (BMI), total protein, alanine aminotransferases have some influence on fentanyl serum concentration and the dose of TDF. Furthermore, the clinical factors seem to have a greater impact on the effectiveness of TDF than the genetic factors which may affect the liver metabolism of fentanyl. Based on these results, we aim to investigate the correlation and quantitative relationship between the analgesic effect of fentanyl transdermal patches in cancer pain patients and their nutritional status. Our purpose is to help clinicians recognize and increase the analgesic effect of TDF according to the patient's risk level. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06369961
Study type	Observational
Source	Chongqing University Cancer Hospital
Contact
Status	Completed
Phase
Start date	March 1, 2023
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03438942` - Influence of Iron and Foliate Transporters on Bioavailability of These Micronutrients in the Organism	N/A
Recruiting	`NCT04475666` - Replacing Protein Via Enteral Nutrition in Critically Ill Patients	N/A
Recruiting	`NCT02763878` - Uncut Roux-en-y Anastomosis Reduce Postoperative Complication and Improve Nutritional Status After Distal Gastrectomy	Phase 3
Completed	`NCT02402985` - Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics	N/A
Completed	`NCT02039596` - Nutritional Metabolomics: the Search for Dietary Exposure Variables	N/A
Active, not recruiting	`NCT00996528` - Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)	Phase 3
Active, not recruiting	`NCT04170348` - Daily Vitamin D for Sickle-cell Respiratory Complications	Phase 2
Active, not recruiting	`NCT03843424` - Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers	N/A
Recruiting	`NCT05348590` - Phase-Germ Project: Muscle Mass and Phase Angle in Surgical Patient
Completed	`NCT03440593` - Indirect Calorimetry Usage and Effect in Ventilator-free Days and Muscle Thickness in Septic Ventilated Patients	N/A
Recruiting	`NCT04554758` - Comparative Analysis Between Sleeve Gastrectomy and Roux-en Y Gastric Bypass in Bariatric Operation	N/A
Recruiting	`NCT04389424` - Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer
Completed	`NCT03772171` - Estimate for Dietary Intakes and Hemodialysis Patients
Completed	`NCT01708681` - Lean Seafood Intake and Postprandial Metabolism	N/A
Completed	`NCT01211301` - Medifast 5 & 1 Plan	N/A
Completed	`NCT01081587` - Preventing Malnutrition and Restoring Nutritional Status in Hospitalized Children	N/A
Active, not recruiting	`NCT03865706` - Inulin for Infections in the Intensive Care Unit	Phase 2
Recruiting	`NCT05276752` - Short- and Long-term Health Adverse Outcomes Associated With Nutrition Disorders and Nutrition Related Conditions in Hospitalized Older People
Recruiting	`NCT03643341` - Family Healthy Living Early Intervention Program	N/A
Not yet recruiting	`NCT03618329` - Effect of Prehabilitation on the Lean Mass Index (IMM) in ERAS PROGRAMM.	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms